Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study

Area of Science:

• Infectious Diseases
• Hematology
• Critical Care Medicine

Background:

• Staphylococcus aureus bacteremia (SAB) is a significant clinical challenge, particularly in patients with hematologic malignancies.
• Limited data exist regarding the clinical characteristics and outcomes of SAB in this vulnerable patient population.

Purpose of the Study:

• To investigate the clinical features and outcomes of Staphylococcus aureus bacteremia (SAB) in patients with hematologic malignancies.
• To compare SAB outcomes with Gram-negative bacteremia (GNB) in neutropenic hematologic patients.
• To assess the impact of neutropenia on SAB outcomes.

Main Methods:

• Retrospective study analyzing all episodes of SAB between January 1997 and June 2001.
• Clinical records were reviewed to define SAB episodes and gather data on patient characteristics and outcomes.
• Statistical comparisons were made between different patient groups (neutropenic vs. non-neutropenic, SAB vs. GNB).

Main Results:

• Nosocomial SAB had a low mortality rate (3.5%) with no secondary complications.
• Neutropenic hematologic patients with SAB had lower mortality and less frequent severe sepsis/septic shock compared to those with GNB.
• Non-neutropenic patients experienced significantly higher morbidity and mortality rates, including increased susceptibility to early (severe sepsis, septic shock) and late complications (endocarditis, metastatic abscesses).

Conclusions:

• Staphylococcus aureus bacteremia in hematologic malignancy patients is often a low-inoculum infection.
• Negligible morbidity and mortality rates are associated with SAB in this group, particularly when prompt, adequate antistaphylococcal therapy is administered.
• Early and late complications are more prevalent in non-neutropenic patients compared to neutropenic patients with hematologic malignancies.